Literature DB >> 8489448

Progression of early glaucomatous visual field loss as detected by blue-on-yellow and standard white-on-white automated perimetry.

C A Johnson1, A J Adams, E J Casson, J D Brandt.   

Abstract

OBJECTIVE: To determine whether blue-on-yellow perimetry reveals progression of glaucomatous damage before it is evident with standard white-on-white perimetry.
DESIGN: A Humphrey field analyzer (Humphrey Instruments, San Leandro, Calif) was modified to perform blue-on-yellow perimetry to isolate and measure the sensitivity of short wavelength-sensitive mechanisms. Participants were tested annually with standard white-on-white automated perimetry and blue-on-yellow automated perimetry for 5 years. PATIENTS: Sixteen patients with early glaucomatous visual field loss in one or both eyes and 62 age-matched normal control subjects.
RESULTS: At baseline, 25 (78.1%) of the 32 eyes exhibited larger deficits with blue-on-yellow perimetry, five (15.6%) had equivalent loss with both tests, and two (6.3%) had larger deficits with standard white-on-white perimetry. Seven (21.9%) of the 32 eyes demonstrated evidence of progressive visual field loss with standard white-on-white perimetry in 5 years, while the other 25 eyes (78.1%) were relatively stable. Deficits with blue-on-yellow perimetry were twice as large as deficits with white-on-white perimetry in the stable group and were three to four times as large in the group with progressive field loss.
CONCLUSIONS: Blue-on-yellow perimetry is effective in predicting which patients with early glaucomatous visual field loss are most likely to have progressive loss. The rate of progressive loss is greater with blue-on-yellow perimetry than with standard white-on-white perimetry.

Entities:  

Mesh:

Year:  1993        PMID: 8489448     DOI: 10.1001/archopht.1993.01090050085035

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  37 in total

Review 1.  Acquired colour vision defects in glaucoma-their detection and clinical significance.

Authors:  M Pacheco-Cutillas; D F Edgar; A Sahraie
Journal:  Br J Ophthalmol       Date:  1999-12       Impact factor: 4.638

2.  GDx VCC measurements and blue-on-yellow perimetry in ocular hypertension.

Authors:  Yisheng Zhong; Liping Chen; Yu Cheng; Fangzhi Yu
Journal:  Lasers Med Sci       Date:  2012-02-03       Impact factor: 3.161

Review 3.  [Functional glaucoma diagnosis].

Authors:  C Erb; K Göbel
Journal:  Ophthalmologe       Date:  2009-04       Impact factor: 1.059

4.  Blue-on-yellow perimetry and corneal thickness in patients with ocular hypertension.

Authors:  Yi-Sheng Zhong; Li-Ping Chen; Yu Cheng
Journal:  Int J Ophthalmol       Date:  2011-12-18       Impact factor: 1.779

5.  Baseline alterations in blue-on-yellow normal perimetric sensitivity.

Authors:  J M Wild; I D Moss
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-03       Impact factor: 3.117

6.  Agreement between frequency-doubling technology perimetry and Heidelberg retinal tomography 3.

Authors:  Na Young Lee; Hye Jin Chung; Chan Kee Park
Journal:  Jpn J Ophthalmol       Date:  2013-01-11       Impact factor: 2.447

7.  Evaluation of corpus geniculatum laterale and vitreous fluid by magnetic resonance spectroscopy in patients with glaucoma; a preliminary study.

Authors:  S Doganay; C Cankaya; A Alkan
Journal:  Eye (Lond)       Date:  2012-05-25       Impact factor: 3.775

8.  Color axis evaluation of the Farnsworth Munsell 100-hue test in primary open-angle glaucoma and normal-pressure glaucoma.

Authors:  W M Budde; A Jünemann; M Korth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

9.  Impaired motion sensitivity as a predictor of subsequent field loss in glaucoma suspects: the Roscommon Glaucoma Study.

Authors:  J Wu; M Coffey; A Reidy; R Wormald
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

10.  Evaluation of S-cone sensitivity in reattached macula following macula-off retinal detachment surgery.

Authors:  Tsutomu Sakai; Kazuyuki Iida; Yuichiro Tanaka; Kenichi Kohzaki; Kenji Kitahara
Journal:  Jpn J Ophthalmol       Date:  2005 Jul-Aug       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.